Pacliltaxel USP39
Product Description
Shanghai Jinhe Bio-pharmaceuticalCo., Lt
-
CN
-
2016On CPHI since
Categories
Shanghai Jinhe Bio-pharmaceuticalCo., Lt
-
CN
-
2016On CPHI since
More Products from Shanghai Jinhe Bio-pharmaceuticalCo., Lt (10)
-
Product 7-troc-Paclitaxel, CAS:114915-17-2
Paclitaxel N-1, -
Product 7,10-di-Troc-Docetaxel
Docetaxel N-1, CAS: 114915-14-9 -
Product Cabazitaxel
inhouse standard -
Product Docetaxel
Docetaxel, sold under the brand name Taxotere among others, is a chemotherapy medication used to treat a number of types of cancer.[1] This includes breast cancer, head and neck cancer, stomach cancer, prostate cancer and non small-cell lung cancer.[2] It may be used by itself or along with other chemother... -
Product Docetaxel side chain, CAS: 949023-16-9
quantity above 1000kgs -
Product Irinotecan HCl Trihydrate USP39
Annual production ability above 100kgs. -
Product Paclitaxel side chain CAS: 196404-55-4
ANNUAL production ability above 1000kgs -
Product Palonosetron HCl
inhouse standard
-
Product 10 DABIII
Annal production ability above 1000kgs -
Product 4'-Demethyl-epi-Podophyllotoxin CAS: 6559-91-7
could provide CITEs
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance